InnovHeart has first in-human implantation of its TMVR massdevice.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from massdevice.com Daily Mail and Mail on Sunday newspapers.
Ensoma, a genomic medicines company developing one-time in vivo treatments that precisely engineer any cell of the hematopoietic system to cure diseases from within, today announced the closing of its
DJ Portfolio company Twelve Bio to be acquired alongside USD85 million financing of Ensoma Arix Bioscience PLC (ARIX) Portfolio company Twelve Bio to be acquired alongside USD85 million financing